Terveystalo Oy Ord (TTALF) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning all. My name is Juuso Pajunen. I will be having today a dual role as the host of the Terveystalo half-year result presentation and as a CFO at a later stage. But let's now give the word to Ville Iho, President and CEO of Terveystalo, and let's start the webcast for the half-year results. Ville, please. Thank you, Juuso, and good morning from sunny Helsinki. Let's start recapping Terveystalo second quarter. Of course, it was a busy quarter for Terveystalo. We, of course, released multiple big things, not the least Silma-Asema acquisition, our new financial targets and our new strategy. On a business side, it was still a challenging quarter. The market conditions continue to be abnormally negative and that has been reflecting into our revenue line and with that one also to profitability to our numbers. We made adjustments according to the lower volumes and given that one, given the actions we took, we can be of course pleased with the Customer service results, customer experience numbers are all-time high as well as medical quality key indicator pay. But revenue line obviously negative as well as adjusted EBIT EPS and also net debt to EBITDA leverage ratio went slightly up. Double clicking on those negative market drivers. First of all... Public purchases from private healthcare, which are not even seen in this slide, were still almost non-existent. So healthcare counties have insourced quite a bit of their activities, and they are still reorganizing the cooperation models with private healthcare providers. So that was clearly negative. Then from our biggest business, occupational healthcare services, the number of employed persons in Finland, which is the baseline of the baseline, was negative. It was still down from the baseline. Previous Q2, on top of t...